Status: This program has closed
We are no longer accepting new proposals.
Hosted by the Human Health Therapeutics Research Centre, the Disruptive Technology Solutions for Cell and Gene Therapy Challenge program was created to advance the development and manufacturing of cell and gene therapies for chronic diseases and rare genetic disorders in Canada.
It brought together researchers, clinicians and industry partners to reduce manufacturing costs and make cell and gene therapies more accessible for Canadians.
Program highlights
The program strengthened Canada's expertise in cell and gene therapy through targeted research and collaboration.